Traded Jun 1 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded May 5, 2026 · Filed May 7, 2026
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
grant award
Code A — grant or award
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Traded Jun 1 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Helen Torley (PRESIDENT AND CEO) sold ~$107K of Halozyme
Scheduled in advanceHelen Torley (PRESIDENT AND CEO) sold ~$876K of Halozyme
Scheduled in advance